Alpheus Medical

Executive Summary

Alpheus Medical is a privately-held ophthalmology medical device company founded in 2015 and headquartered in San Diego, CA. The company is developing a novel therapeutic approach aimed at improving clinical outcomes while reducing the treatment burden for patients and their families. Currently in Phase 2, Alpheus's platform targets significant unmet needs in ophthalmic care, potentially offering a differentiated solution that could shift standard of practice. The company's technology is designed to be less invasive and more convenient than existing treatments, which may improve patient compliance and quality of life. With a strong focus on patient-centric innovation, Alpheus is positioned to address a sizable market opportunity in eye disease management.

Upcoming Catalysts (preview)

• Q4 2026Phase 2 Pivotal Study Results60% success
• Q2 2026FDA Pre-Submission Meeting70% success
• Q1 2027Strategic Partnership or Licensing Deal45% success